Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Eoganachton Oct 09, 2022 7:14pm
269 Views
Post# 35015163

RE:BTD and AA

RE:BTD and AAIf Theralase gets accelerated approval to commercialize it's side-effect free, efficacious cancer treatment I don't think money will be an issue.

Consider some of the long term side effects of existing cancer treatments:

Chemotherapy
Dental problems
Early menopause
Hearing loss
Heart problems
Increased risk of other cancers
Infertility
Loss of taste
Lung disease
Nerve damage
Osteoporosis
Reduced lung capacity
 
Radiation therapy
Cavities and tooth decay
Early menopause
Heart and vascular problems
Hypothyroidism
Increased risk of other cancers
Increased risk of stroke
Infertility
Intestinal problems
Lung disease
Lymphedema
Memory problems
Osteoporosis
 
Surgery
Lymphedema
 
Hormone therapy
Blood clots
Hot flashes (in men as well as in women)
Increased risk of other cancers
Menopausal symptoms
Osteoporosis
Sexual side effects (men and women)

https://www.mayoclinic.org/diseases-conditions/cancer/in-depth/cancer-survivor/art-20045524

As far as number of treatments, chemotherapy may involve 24 treatments over an 8 month period. Radiation therapy may involve 50 treatments over a period of 10 weeks. For some forms of breast cancer hormone therapy might be taken daily for 5 to 10 years.

Theralase will be offering a one and done treatment for NMIBC. (Or 2 treatments at the most)
 
jmm1228 wrote: These, when they happen, bring on a new level of expense which TLT must be prepared to handle.


<< Previous
Bullboard Posts
Next >>